This editorial examines Miwa et al's article entitled “Phase 1/2 Study of Immunotherapy With Dendritic Cells Pulsed With Autologous Tumor Lysate in Patients With Refractory Bone and Soft Tissue Sarcoma: A Safe Method for Inducing an Immunological Response but With Limited Effects on Clinical Outcomes,” which appears in the current issue of Cancer. The state of the art of autologous cancer vaccines is briefly reviewed, and suggestions for improved immunological therapy for sarcomas are discussed. See also pages 000-000.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2lNu4ky
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου